NPRTX
Price
$49.92
Change
+$0.05 (+0.10%)
Updated
Sep 8 closing price
Net Assets
8.31B
VIVAX
Price
$71.08
Change
-$0.13 (-0.18%)
Updated
Sep 8 closing price
Net Assets
202.84B
Interact to see
Advertisement

NPRTX vs VIVAX

Header iconNPRTX vs VIVAX Comparison
Open Charts NPRTX vs VIVAXBanner chart's image
Neuberger Berman Large Cap Value I
Price$49.92
Change+$0.05 (+0.10%)
VolumeN/A
Net Assets8.31B
Vanguard Value Index I
Price$71.08
Change-$0.13 (-0.18%)
VolumeN/A
Net Assets202.84B
NPRTX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NPRTX vs. VIVAX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NPRTX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 203B vs. NPRTX (8.31B). VIVAX (1.99) and NPRTX (1.96) have matching dividends . NPRTX was incepted earlier than VIVAX: NPRTX (51 years) vs VIVAX (33 years). NPRTX (0.76) is less costly to investors than VIVAX (0.17). NPRTX is a more actively managed with annual turnover of: 81.00 vs. VIVAX (9.00). NPRTX has a lower initial minimum investment than VIVAX: NPRTX (1000) vs VIVAX (3000). NPRTX annual gain was more profitable for investors over the last year : 9.05 vs. VIVAX (7.74). NPRTX return over 5 years is better than : 78.28 vs. VIVAX (70.18).
NPRTXVIVAXNPRTX / VIVAX
Total Expense Ratio0.760.17447%
Annual Report Gross Expense Ratio0.760.17447%
Fund Existence51 years33 years-
Gain YTD11.1197.845142%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets8.31B203B4%
Annual Yield % from dividends1.961.9999%
Returns for 1 year9.057.74117%
Returns for 3 years30.6836.6384%
Returns for 5 years78.2870.18112%
Returns for 10 years107.23131.6481%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JAGLX70.010.54
+0.78%
Janus Henderson Global Life Sciences T
RFNBX90.230.50
+0.56%
American Funds Fundamental Invs R2
LICYX17.900.09
+0.51%
Lord Abbett International Equity I
MGBRX17.760.03
+0.17%
MFS Global Total Return R2
ETMGX31.780.05
+0.16%
Eaton Vance Tx-Mgd Small-Cap A